Report Thumbnail
Product Code DB0910812468QW
Published Date 2023/5/1
English506 PagesNorth America

NA Medical Cannabis Market - Industry Trends and Forecast to 2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code DB0910812468QW◆The May 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/5/1
English 506 PagesNorth America

NA Medical Cannabis Market - Industry Trends and Forecast to 2030Pharmaceutical_LifeSciense Market



Abstract


Summary

The North America medical cannabis market is expected to reach USD 44,585.21 million by 2030 from USD 8,452.33 million in 2022, growing at a CAGR of 23.2% during the forecast period of 2023 to 2030. Market Segmentation North America Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C), Country (U.S., Canada, and Mexico) – Industry Trends and Forecast to 2030 Overview of North America Medical Cannabis Market Dynamics Driver • Increased medical use of cannabis Restraint • The complex regulatory structure for the usage of cannabis Opportunity • Novel product development with increasing R&D activities Market Players Some of the major market players operating in the North America medical cannabis market are: • MediPharm Labs Inc. • Tilray • Aurora Cannabis • JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc) • HEXO Corp. (Zenabis Global Ltd) • Cresco Labs • Peace Naturals Project Inc. • CANOPY GROWTH CORPORATION • Medical Marijuana, Inc. • Seed Cellar • EcoGen Biosciences • CANNABIS SEEDS USA • Seeds For Me • HUMBOLDT SEED COMPANY • Extractas • World Class Cannabis Seeds (Crop King Seeds) • BARNEY'S FARM • FOLIUM BIOSCIENCES • PharmaHemp • Elixinol Global Limited • ENDOCA • Harmony • MARY’S nutritionals, LLC • Pure Ratios • Greenwich Biosciences, Inc. • Upstate Elevator Supply Co. • Apothecanna • BOL Pharma • IDT Australia

Table of Contents

  • 1 INTRODUCTION 156

    • 1.1 OBJECTIVES OF THE STUDY 156
    • 1.2 MARKET DEFINITION 156
    • 1.3 OVERVIEW OF THE NORTH AMERICA MEDICAL CANNABIS MARKET 156
    • 1.4 LIMITATIONS 158
    • 1.5 MARKETS COVERED 159
  • 2 MARKET SEGMENTATION 168

    • 2.1 MARKETS COVERED 168
    • 2.2 GEOGRAPHICAL SCOPE 169
    • 2.3 YEARS CONSIDERED FOR THE STUDY 170
    • 2.4 CURRENCY AND PRICING 170
    • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 171
    • 2.6 MULTIVARIATE MODELLING 174
    • 2.7 PRODUCT LIFELINE CURVE 174
    • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 175
    • 2.9 DBMR MARKET POSITION GRID 176
    • 2.10 MARKET APPLICATION COVERAGE GRID 178
    • 2.11 VENDOR SHARE ANALYSIS 179
    • 2.12 SECONDARY SOURCES 180
    • 2.13 ASSUMPTIONS 180
  • 3 EXECUTIVE SUMMARY 181

  • 4 PREMIUM INSIGHTS 184

    • 4.1 PESTEL ANALYSIS 187
    • 4.2 PORTER’S FIVE FORCES 188
  • 5 INDUSTRY INSIGHTS 189

    • 5.1 INDUSTRY INSIGHTS PATENT ANALYSIS 189
    • 5.2 DRUG TREATMENT RATE BY MATURED MARKETS 196
    • 5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 197
    • 5.4 PATIENT FLOW DIAGRAM 198
    • 5.5 KEY PRICING STRATEGIES 199
    • 5.6 KEY PATIENT ENROLLMENT STRATEGIES 200
  • 6 REGULATORY SCENARIO 201

    • 6.1 U.S 201
    • 6.2 CANADA 202
    • 6.3 MEXICO 203
  • 7 MARKET OVERVIEW 205

    • 7.1 DRIVERS 206
      • 7.1.1 INCREASED USE OF CANNABIS IN MEDICINES 206
      • 7.1.2 LEGALIZATION OF CANNABIS 206
      • 7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS 206
      • 7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS 207
    • 7.2 RESTRAINTS 208
      • 7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS 208
      • 7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE 208
      • 7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY 209
    • 7.3 OPPORTUNITIES 209
      • 7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES 209
      • 7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES 209
      • 7.3.3 GROWING GERIATRIC POPULATION 210
    • 7.4 CHALLENGES 210
      • 7.4.1 RISE OF THE CANNABIS BLACK MARKET 210
      • 7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS 211
      • 7.4.3 SHORTAGE OF SKILLED PERSONNEL 211
  • 8 NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT 212

    • 8.1 OVERVIEW 213
    • 8.2 OIL 217
      • 8.2.1 OIL, BY TYPE 217
        • 8.2.1.1 CBD OIL CONCENTRATES 217
        • 8.2.1.2 CBD VAPE OIL 218
        • 8.2.1.3 CBD TINCTURES 218
      • 8.2.2 OIL, BY SOURCE 218
        • 8.2.2.1 HEMP BASED 218
        • 8.2.2.2 MARIJUANA BASED 218
      • 8.2.3 OIL, BY SPECIES 218
        • 8.2.3.1 SATIVA 218
        • 8.2.3.2 HYBRID 219
        • 8.2.3.3 CANNABIS INDICA 219
      • 8.2.4 OIL, BY PRODUCT TYPE 219
        • 8.2.4.1 BRANDED 219
          • 8.2.4.1.1 PENGUIN CBD OIL 219
          • 8.2.4.1.2 FAB CBD OIL 220
          • 8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL 220
          • 8.2.4.1.4 OTHERS 220
        • 8.2.4.2 GENERIC 220
    • 8.3 DRIED MEDICAL CANNABIS 220
      • 8.3.1 CANNABIS INDICA 221
      • 8.3.2 SATIVA 221
      • 8.3.3 HYBRID 221
    • 8.4 MEDICAL CANNABIS CAPSULES 222
      • 8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE 222
        • 8.4.1.1 OIL BASED CANNABIS CAPSULES 223
        • 8.4.1.2 POWDER BASED CANNABIS CAPSULES 223
        • 8.4.1.3 LIQUID BASED CANNABIS CAPSULES 223
        • 8.4.1.4 OTHERS 223
      • 8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES 223
        • 8.4.2.1 HIGH CBD CAPSULES DIGITAL 223
        • 8.4.2.2 HIGH THC CAPSULE 223
        • 8.4.2.3 THC/CBD BALANCED CAPSULE 224
        • 8.4.2.4 CBD ISOLATE CAPSULE 224
      • 8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES 224
        • 8.4.3.1 SATIVA 224
        • 8.4.3.2 CANNABIS INDICA 224
      • 8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE 224
        • 8.4.4.1 BRANDED 225
          • 8.4.4.1.1 JOY NUTRITION 225
          • 8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES 225
          • 8.4.4.1.3 LAZARUS NATURALS 225
          • 8.4.4.1.4 OTHERS 225
        • 8.4.4.2 GENERIC 225
    • 8.5 VAPE PEN 225
      • 8.5.1 VAPE PEN, BY SPECIES 226
        • 8.5.1.1 SATIVA 226
        • 8.5.1.2 HYBRID 226
        • 8.5.1.3 CANNABIS INDICA 227
      • 8.5.2 VAPE PEN, BY PRODUCT TYPE 227
        • 8.5.2.1 BRANDED 227
          • 8.5.2.1.1 KANDYPENS RUBI 227
          • 8.5.2.1.2 SOL E-NECTAR COLLECTOR 227
          • 8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN 228
        • 8.5.2.2 GENERIC 228
    • 8.6 WHOLE FLOWER 228
      • 8.6.1 WHOLE FLOWER, SPECIES 228
        • 8.6.1.1 SATIVA 229
        • 8.6.1.2 HYBRID 229
        • 8.6.1.3 CANNABIS INDICA 229
      • 8.6.2 WHOLE FLOWER, PRODUCT TYPE 229
        • 8.6.2.1 BRANDED 230
          • 8.6.2.1.1 ASTER FARMS 230
          • 8.6.2.1.2 RA FLOWER 230
          • 8.6.2.1.3 BAD APPLE 230
        • 8.6.2.2 GENERIC 230
    • 8.7 CREAMS & MOISTURIZER 231
      • 8.7.1 CREAMS & MOISTURIZER, BY SPECIES 231
        • 8.7.1.1 SATIVA 232
        • 8.7.1.2 HYBRID 232
        • 8.7.1.3 CANNABIS INDICA 232
      • 8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE 232
        • 8.7.2.1 BRANDED 232
          • 8.7.2.1.1 CBDFX MUSCLE & JOINT 233
          • 8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM 233
          • 8.7.2.1.3 MEDTERRA PAIN CREAM 233
        • 8.7.2.2 GENERIC 233
    • 8.8 GROUND FLOWER 233
      • 8.8.1 GROUND FLOWER, BY SPECIES 234
        • 8.8.1.1 SATIVA 234
        • 8.8.1.2 HYBRID 234
        • 8.8.1.3 CANNABIS INDICA 234
      • 8.8.2 GROUND FLOWER, BY PRODUCT TYPE 234
        • 8.8.2.1 BRANDED 235
          • 8.8.2.1.1 ASTER FARMS 235
          • 8.8.2.1.2 RA FLOWER 235
          • 8.8.2.1.3 BAD APPLE 235
        • 8.8.2.2 GENERIC 235
    • 8.9 PATCH 236
      • 8.9.1 PATCH, BY TYPE 236
        • 8.9.1.1 RESERVOIR 236
        • 8.9.1.2 LAYER DRUG-IN-ADHESIVE 236
        • 8.9.1.3 OTHERS 237
      • 8.9.2 PATCH, BY SPECIES 237
        • 8.9.2.1 SATIVA 237
        • 8.9.2.2 CANNABIS INDICA 237
        • 8.9.2.3 HYBRID 237
      • 8.9.3 PATCH, BY PRODUCT TYPE 237
        • 8.9.3.1 BRANDED 237
          • 8.9.3.1.1 HEMP BOMBS 238
          • 8.9.3.1.2 PUREKANA 238
          • 8.9.3.1.3 PURE RATIOS 238
          • 8.9.3.1.4 RESERVOIR 238
        • 8.9.3.2 GENERIC 238
    • 8.10 MASKS & SERUM 239
      • 8.10.1 MASKS & SERUM, BY SPECIES 239
        • 8.10.1.1 SATIVA 240
        • 8.10.1.2 CANNABIS INDICA 240
        • 8.10.1.3 HYBRID 240
      • 8.10.2 MASKS & SERUM, BY PRODUCT TYPE 240
        • 8.10.2.1 BRANDED 240
          • 8.10.2.1.1 BUMP & SMOOTH CBD 240
          • 8.10.2.1.2 FACIAL ESSENCE 241
          • 8.10.2.1.3 OTHERS 241
        • 8.10.2.2 GENERIC 241
    • 8.11 CLEANSER 241
      • 8.11.1 CLEANSER, BY SPECIES 241
        • 8.11.1.1 SATIVA 242
        • 8.11.1.2 HYBRID 242
        • 8.11.1.3 CANNABIS INDICA 242
      • 8.11.2 CLEANSER, BY PRODUCT TYPE 242
        • 8.11.2.1 BRANDED 243
          • 8.11.2.1.1 KIEHL’S 243
          • 8.11.2.1.2 CBD 101 243
          • 8.11.2.1.3 OTHERS 243
        • 8.11.2.2 GENERIC 243
    • 8.12 OTHERS 244
  • 9 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES 245

    • 9.1 OVERVIEW 246
    • 9.2 SATIVA 249
    • 9.3 HYBRID 250
    • 9.4 CANNABIS INDICA 251
  • 10 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES 252

    • 10.1 OVERVIEW 253
    • 10.2 CANNABIDIOL (CBD) 256
    • 10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL 256
    • 10.4 CANNABIGEROL (CBG) 257
    • 10.5 CANNABICHROMENE (CBC) 258
    • 10.6 CANNABINOL (CBN) 259
    • 10.7 CANNABICYCLOL (CBL) 260
    • 10.8 OTHERS 261
  • 11 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION 262

    • 11.1 OVERVIEW 263
    • 11.2 PAIN MANAGEMENT 267
      • 11.2.1 PAIN MANAGEMENT, BY TYPE 267
        • 11.2.1.1 CHRONIC PAIN 267
        • 11.2.1.2 NON-CANCER CHRONIC PAIN 268
        • 11.2.1.3 NEUROLOGICAL PAIN 268
      • 11.2.2 PAIN MANAGEMENT, BY PRODUCT 268
        • 11.2.2.1 OIL 268
        • 11.2.2.2 DRIED MEDICAL CANNABIS 268
        • 11.2.2.3 MEDICAL CANNABIS CAPSULES 268
        • 11.2.2.4 PATCH 269
        • 11.2.2.5 GROUND FLOWER 269
        • 11.2.2.6 CREAMS & MOISTURIZER 269
        • 11.2.2.7 VAPE PEN 269
        • 11.2.2.8 WHOLE FLOWER 269
        • 11.2.2.9 MASKS & SERUM 269
        • 11.2.2.10 CLEANSER 269
        • 11.2.2.11 OTHERS 269
    • 11.3 ANXIETY 269
      • 11.3.1 OIL 270
      • 11.3.2 DRIED MEDICAL CANNABIS 270
      • 11.3.3 MEDICAL CANNABIS CAPSULES 271
      • 11.3.4 PATCH 271
      • 11.3.5 GROUND FLOWER 271
      • 11.3.6 CREAMS & MOISTURIZER 271
      • 11.3.7 VAPE PEN 271
      • 11.3.8 WHOLE FLOWER 271
      • 11.3.9 MASKS & SERUM 271
      • 11.3.10 CLEANSER 271
      • 11.3.11 OTHERS 271
    • 11.4 MUSCLE SPASM 272
      • 11.4.1 OIL 273
      • 11.4.2 DRIED MEDICAL CANNABIS 273
      • 11.4.3 MEDICAL CANNABIS CAPSULES 273
      • 11.4.4 PATCH 273
      • 11.4.5 GROUND FLOWER 273
      • 11.4.6 CREAMS & MOISTURIZER 273
      • 11.4.7 VAPE PEN 274
      • 11.4.8 WHOLE FLOWER 274
      • 11.4.9 MASKS & SERUM 274
      • 11.4.10 CLEANSER 274
      • 11.4.11 OTHERS 274
    • 11.5 NAUSEA 274
      • 11.5.1 OIL 275
      • 11.5.2 DRIED MEDICAL CANNABIS 275
      • 11.5.3 MEDICAL CANNABIS CAPSULES 275
      • 11.5.4 PATCH 275
      • 11.5.5 GROUND FLOWER 275
      • 11.5.6 CREAMS & MOISTURIZER 276
      • 11.5.7 VAPE PEN 276
      • 11.5.8 WHOLE FLOWER 276
      • 11.5.9 MASKS & SERUM 276
      • 11.5.10 CLEANSER 276
      • 11.5.11 OTHERS 276
    • 11.6 APPETITE LOSS 276
      • 11.6.1 OIL 277
      • 11.6.2 DRIED MEDICAL CANNABIS 277
      • 11.6.3 MEDICAL CANNABIS CAPSULES 278
      • 11.6.4 PATCH 278
      • 11.6.5 GROUND FLOWER 278
      • 11.6.6 CREAMS & MOISTURIZER 278
      • 11.6.7 VAPE PEN 278
      • 11.6.8 WHOLE FLOWER 278
      • 11.6.9 MASKS & SERUM 278
      • 11.6.10 CLEANSER 278
      • 11.6.11 OTHERS 278
    • 11.7 EATING DISORDERS 279
      • 11.7.1 OIL 280
      • 11.7.2 DRIED MEDICAL CANNABIS 280
      • 11.7.3 MEDICAL CANNABIS CAPSULES 280
      • 11.7.4 PATCH 280
      • 11.7.5 GROUND FLOWER 280
      • 11.7.6 CREAMS & MOISTURIZER 281
      • 11.7.7 VAPE PEN 281
      • 11.7.8 WHOLE FLOWER 281
      • 11.7.9 MASKS & SERUM 281
      • 11.7.10 CLEANSER 281
      • 11.7.11 OTHERS 281
    • 11.8 INFLAMMATORY BOWEL DISEASES 281
      • 11.8.1 OIL 282
      • 11.8.2 DRIED MEDICAL CANNABIS 282
      • 11.8.3 MEDICAL CANNABIS CAPSULES 283
      • 11.8.4 PATCH 283
      • 11.8.5 GROUND FLOWER 283
      • 11.8.6 CREAMS & MOISTURIZER 283
      • 11.8.7 VAPE PEN 283
      • 11.8.8 WHOLE FLOWER 283
      • 11.8.9 MASKS & SERUM 283
      • 11.8.10 CLEANSER 283
      • 11.8.11 OTHERS 283
    • 11.9 CANCER 284
      • 11.9.1 OIL 285
      • 11.9.2 DRIED MEDICAL CANNABIS 285
      • 11.9.3 MEDICAL CANNABIS CAPSULES 285
      • 11.9.4 PATCH 285
      • 11.9.5 GROUND FLOWER 285
      • 11.9.6 CREAMS & MOISTURIZER 286
      • 11.9.7 VAPE PEN 286
      • 11.9.8 WHOLE FLOWER 286
      • 11.9.9 MASKS & SERUM 286
      • 11.9.10 CLEANSER 286
      • 11.9.11 OTHERS 286
    • 11.10 ARTHRITIS 286
      • 11.10.1 OIL 287
      • 11.10.2 DRIED MEDICAL CANNABIS 287
      • 11.10.3 MEDICAL CANNABIS CAPSULES 287
      • 11.10.4 PATCH 287
      • 11.10.5 GROUND FLOWER 287
      • 11.10.6 CREAMS & MOISTURIZER 288
      • 11.10.7 VAPE PEN 288
      • 11.10.8 WHOLE FLOWER 288
      • 11.10.9 MASKS & SERUM 288
      • 11.10.10 CLEANSER 288
      • 11.10.11 OTHERS 288
    • 11.11 WASHING SYNDROME (CACHEXIA) 288
      • 11.11.1 OIL 289
      • 11.11.2 DRIED MEDICAL CANNABIS 289
      • 11.11.3 MEDICAL CANNABIS CAPSULES 289
      • 11.11.4 PATCH 289
      • 11.11.5 GROUND FLOWER 289
      • 11.11.6 CREAMS & MOISTURIZER 290
      • 11.11.7 VAPE PEN 290
      • 11.11.8 WHOLE FLOWER 290
      • 11.11.9 MASKS & SERUM 290
      • 11.11.10 CLEANSER 290
      • 11.11.11 OTHERS 290
    • 11.12 ALZHEIMER’S DISEASE 290
      • 11.12.1 OIL 291
      • 11.12.2 DRIED MEDICAL CANNABIS 291
      • 11.12.3 MEDICAL CANNABIS CAPSULES 292
      • 11.12.4 PATCH 292
      • 11.12.5 GROUND FLOWER 292
      • 11.12.6 CREAMS & MOISTURIZER 292
      • 11.12.7 VAPE PEN 292
      • 11.12.8 WHOLE FLOWER 292
      • 11.12.9 MASKS & SERUM 292
      • 11.12.10 CLEANSER 292
      • 11.12.11 OTHERS 292
    • 11.13 EPILEPSY 293
      • 11.13.1 OIL 294
      • 11.13.2 DRIED MEDICAL CANNABIS 294
      • 11.13.3 MEDICAL CANNABIS CAPSULES 294
      • 11.13.4 PATCH 294
      • 11.13.5 GROUND FLOWER 294
      • 11.13.6 CREAMS & MOISTURIZER 295
      • 11.13.7 VAPE PEN 295
      • 11.13.8 WHOLE FLOWER 295
      • 11.13.9 MASKS & SERUM 295
      • 11.13.10 CLEANSER 295
      • 11.13.11 OTHERS 295
    • 11.14 DEPRESSION AND SLEEP DISORDER 295
      • 11.14.1 OIL 296
      • 11.14.2 DRIED MEDICAL CANNABIS 296
      • 11.14.3 MEDICAL CANNABIS CAPSULES 297
      • 11.14.4 PATCH 297
      • 11.14.5 GROUND FLOWER 297
      • 11.14.6 CREAMS & MOISTURIZER 297
      • 11.14.7 VAPE PEN 297
      • 11.14.8 WHOLE FLOWER 297
      • 11.14.9 MASKS & SERUM 297
      • 11.14.10 CLEANSER 297
      • 11.14.11 OTHERS 297
    • 11.15 MULTIPLE SCLEROSIS 298
      • 11.15.1 OIL 299
      • 11.15.2 DRIED MEDICAL CANNABIS 299
      • 11.15.3 MEDICAL CANNABIS CAPSULES 299
      • 11.15.4 PATCH 299
      • 11.15.5 GROUND FLOWER 299
      • 11.15.6 CREAMS & MOISTURIZER 300
      • 11.15.7 VAPE PEN 300
      • 11.15.8 WHOLE FLOWER 300
      • 11.15.9 MASKS & SERUM 300
      • 11.15.10 CLEANSER 300
      • 11.15.11 OTHERS 300
    • 11.16 AUTISM 300
      • 11.16.1 OIL 301
      • 11.16.2 DRIED MEDICAL CANNABIS 301
      • 11.16.3 MEDICAL CANNABIS CAPSULES 302
      • 11.16.4 PATCH 302
      • 11.16.5 GROUND FLOWER 302
      • 11.16.6 CREAMS & MOISTURIZER 302
      • 11.16.7 VAPE PEN 302
      • 11.16.8 WHOLE FLOWER 302
      • 11.16.9 MASKS & SERUM 302
      • 11.16.10 CLEANSER 302
      • 11.16.11 OTHERS 302
    • 11.17 MENTAL HEALTH CONDITIONS 302
      • 11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE 303
        • 11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD) 303
        • 11.17.1.2 SCHIZOPHRENIA 303
        • 11.17.1.3 OTHERS 303
      • 11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE 304
        • 11.17.2.1 OIL 304
        • 11.17.2.2 DRIED MEDICAL CANNABIS 304
        • 11.17.2.3 MEDICAL CANNABIS CAPSULES 304
        • 11.17.2.4 PATCH 304
        • 11.17.2.5 GROUND FLOWER 304
        • 11.17.2.6 CREAMS & MOISTURIZER 305
        • 11.17.2.7 VAPE PEN 305
        • 11.17.2.8 WHOLE FLOWER 305
        • 11.17.2.9 MASKS & SERUM 305
        • 11.17.2.10 CLEANSER 305
        • 11.17.2.11 OTHERS 305
    • 11.18 ELEVATE MOOD 305
      • 11.18.1 OIL 306
      • 11.18.2 DRIED MEDICAL CANNABIS 306
      • 11.18.3 MEDICAL CANNABIS CAPSULES 307
      • 11.18.4 PATCH 307
      • 11.18.5 GROUND FLOWER 307
      • 11.18.6 CREAMS & MOISTURIZER 307
      • 11.18.7 VAPE PEN 307
      • 11.18.8 WHOLE FLOWER 307
      • 11.18.9 MASKS & SERUM 307
      • 11.18.10 CLEANSER 307
      • 11.18.11 OTHERS 307
    • 11.19 OTHERS 308
  • 12 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION 309

    • 12.1 OVERVIEW 310
    • 12.2 ORAL SOLUTIONS AND CAPSULES 313
    • 12.3 SMOKING 314
    • 12.4 TOPICALS 314
    • 12.5 VAPORIZERS 315
    • 12.6 OTHERS 316
  • 13 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE 317

    • 13.1 OVERVIEW 318
    • 13.2 ANALGESIC 321
    • 13.3 PSYCHEDELIC 321
    • 13.4 ANTIVIRAL 322
    • 13.5 APHRODISIAC 323
    • 13.6 EXPECTORANT 323
    • 13.7 OTHERS 324
  • 14 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER 325

    • 14.1 OVERVIEW 326
    • 14.2 HOMECARE SETTING 329
    • 14.3 HOSPITAL 329
    • 14.4 REHAB CENTERS 330
    • 14.5 PHARMACEUTICAL INDUSTRY 331
    • 14.6 RESEARCH AND DEVELOPMENT CENTERS 332
    • 14.7 OTHERS 332
  • 15 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL 333

    • 15.1 OVERVIEW 334
    • 15.2 B2C 337
      • 15.2.1 PHARMACIES 338
      • 15.2.2 CONVENTIONAL STORES 338
      • 15.2.3 ONLINE STORES 338
      • 15.2.4 OTHERS 338
    • 15.3 B2B 338
  • 16 NORTH AMERICA MEDICAL CANNABIS MARKET, BY REGION 339

    • 16.1 NORTH AMERICA 340
      • 16.1.1 U.S 367
      • 16.1.2 CANADA 397
      • 16.1.3 MEXICO 423
  • 17 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE 445

    • 17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 445
  • 18 COMPANY PROFILE 446

    • 18.1 MEDIPHARM LABS INC 446
      • 18.1.1 COMPANY SNAPSHOT 446
      • 18.1.2 REVENUE ANALYSIS 447
      • 18.1.3 COMPANY SHARE ANALYSIS 447
      • 18.1.4 PRODUCT PORTFOLIO 448
      • 18.1.5 RECENT DEVELOPMENTS 448
    • 18.2 TILRAY 450
      • 18.2.1 COMPANY SNAPSHOT 450
      • 18.2.2 COMPANY SHARE ANALYSIS 450
      • 18.2.3 PRODUCT PORTFOLIO 451
      • 18.2.4 RECENT DEVELOPMENTS 451
    • 18.3 AURORA CANNABIS 452
      • 18.3.1 COMPANY SNAPSHOT 452
      • 18.3.2 REVENUE ANALYSIS 452
      • 18.3.3 COMPANY SHARE ANALYSIS 453
      • 18.3.4 PRODUCT PORTFOLIO 453
      • 18.3.5 RECENT DEVELOPMENTS 453
    • 18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC) 455
      • 18.4.1 COMPANY SNAPSHOT 455
      • 18.4.2 REVENUE ANALYSIS 455
      • 18.4.3 COMPANY SHARE ANALYSIS 456
      • 18.4.4 PRODUCT PORTFOLIO 456
      • 18.4.5 RECENT DEVELOPMENTS 456
    • 18.5 HEXO CORP. (ZENABIS NORTH AMERICA LTD) 458
      • 18.5.1 COMPANY SNAPSHOT 458
      • 18.5.2 REVENUE ANALYSIS 458
      • 18.5.3 COMPANY SHARE ANALYSIS 459
      • 18.5.4 PRODUCT PORTFOLIO 459
      • 18.5.5 RECENT DEVELOPMENTS 460
    • 18.6 APOTHECANNA 461
      • 18.6.1 COMPANY SNAPSHOT 461
      • 18.6.2 PRODUCT PORTFOLIO 461
      • 18.6.3 RECENT DEVELOPMENT 462
    • 18.7 BOL PHARMA 463
      • 18.7.1 COMPANY SNAPSHOT 463
      • 18.7.2 PRODUCT PORTFOLIO 463
      • 18.7.3 RECENT DEVELOPMENTS 463
    • 18.8 BARNEY’S FARM 464
      • 18.8.1 COMPANY SNAPSHOT 464
      • 18.8.2 PRODUCT PORTFOLIO 464
      • 18.8.3 RECENT DEVELOPMENTS 465
    • 18.9 CANOPY GROWTH CORPORATION 466
      • 18.9.1 COMPANY SNAPSHOT 466
      • 18.9.2 REVENUE ANALYSIS 466
      • 18.9.3 PRODUCT PORTFOLIO 467
      • 18.9.4 RECENT DEVELOPMENTS 467
    • 18.10 CANNABIS SEEDS USA 469
      • 18.10.1 COMPANY SNAPSHOT 469
      • 18.10.2 PRODUCT PORTFOLIO 469
      • 18.10.3 RECENT DEVELOPMENT 471
    • 18.11 CRESCO LABS 472
      • 18.11.1 COMPANY SNAPSHOT 472
      • 18.11.2 PRODUCT PORTFOLIO 472
      • 18.11.3 RECENT DEVELOPMENTS 474
    • 18.12 ECOGEN BIOSCIENCES 475
      • 18.12.1 COMPANY SNAPSHOT 475
      • 18.12.2 PRODUCT PORTFOLIO 475
      • 18.12.3 RECENT DEVELOPMENTS 475
    • 18.13 ELIXINOL NORTH AMERICA LIMITED 476
      • 18.13.1 COMPANY SNAPSHOT 476
      • 18.13.2 REVENUE ANALYSIS 476
      • 18.13.3 PRODUCT PORTFOLIO 477
      • 18.13.4 RECENT DEVELOPMENTS 477
    • 18.14 ENDOCA 478
      • 18.14.1 COMPANY SNAPSHOT 478
      • 18.14.2 PRODUCT PORTFOLIO 478
      • 18.14.3 RECENT DEVELOPMENT 478
    • 18.15 EXTRACTAS 479
      • 18.15.1 COMPANY SNAPSHOT 479
      • 18.15.2 PRODUCT PORTFOLIO 479
      • 18.15.3 RECENT DEVELOPMENT 479
    • 18.16 FOLIUM BIOSCIENCES 480
      • 18.16.1 COMPANY SNAPSHOT 480
      • 18.16.2 PRODUCT PORTFOLIO 480
      • 18.16.3 RECENT DEVELOPMENTS 481
    • 18.17 GREENWICH BIOSCIENCES, INC 482
      • 18.17.1 COMPANY SNAPSHOT 482
      • 18.17.2 PRODUCT PORTFOLIO 482
      • 18.17.3 RECENT DEVELOPMENTS 482
    • 18.18 HARMONY 483
      • 18.18.1 COMPANY SNAPSHOT 483
      • 18.18.2 PRODUCT PORTFOLIO 483
      • 18.18.3 RECENT DEVELOPMENTS 483
    • 18.19 HUMBOLDT SEED COMPANY 484
      • 18.19.1 COMPANY SNAPSHOT 484
      • 18.19.2 PRODUCT PORTFOLIO 484
      • 18.19.3 RECENT DEVELOPMENT 485
    • 18.20 IDT AUSTRALIA 486
      • 18.20.1 COMPANY SNAPSHOT 486
      • 18.20.2 REVENUE ANALYSIS 486
      • 18.20.3 PRODUCT PORTFOLIO 487
      • 18.20.4 RECENT DEVELOPMENTS 487
    • 18.21 MARY’S NUTRITIONALS, LLC 489
      • 18.21.1 COMPANY SNAPSHOT 489
      • 18.21.2 PRODUCT PORTFOLIO 489
      • 18.21.3 RECENT DEVELOPMENT 489
    • 18.22 MEDICAL MARIJUANA, INC 490
      • 18.22.1 COMPANY SNAPSHOT 490
      • 18.22.2 REVENUE ANALYSIS 490
      • 18.22.3 PRODUCT PORTFOLIO 491
      • 18.22.4 RECENT DEVELOPMENTS 491
    • 18.23 PEACE NATURALS PROJECT INC 492
      • 18.23.1 COMPANY SNAPSHOT 492
      • 18.23.2 PRODUCT PORTFOLIO 492
      • 18.23.3 RECENT DEVELOPMENT 492
    • 18.24 PHARMAHEMP 493
      • 18.24.1 COMPANY SNAPSHOT 493
      • 18.24.2 PRODUCT PORTFOLIO 493
      • 18.24.3 RECENT DEVELOPMENT 493
    • 18.25 PURE RATIOS 494
      • 18.25.1 COMPANY SNAPSHOT 494
      • 18.25.2 PRODUCT PORTFOLIO 494
      • 18.25.3 RECENT DEVELOPMENT 494
    • 18.26 SEEDS FOR ME 495
      • 18.26.1 COMPANY SNAPSHOT 495
      • 18.26.2 PRODUCT PORTFOLIO 495
      • 18.26.3 RECENT DEVELOPMENT 495
    • 18.27 SEED CELLAR 496
      • 18.27.1 COMPANY SNAPSHOT 496
      • 18.27.2 PRODUCT PORTFOLIO 496
      • 18.27.3 RECENT DEVELOPMENT 497
    • 18.28 UPSTATE ELEVATOR SUPPLY CO 498
      • 18.28.1 COMPANY SNAPSHOT 498
      • 18.28.2 PRODUCT PORTFOLIO 498
      • 18.28.3 RECENT DEVELOPMENT 498
    • 18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS) 499
      • 18.29.1 COMPANY SNAPSHOT 499
      • 18.29.2 PRODUCT PORTFOLIO 499
      • 18.29.3 RECENT DEVELOPMENT 500
  • 19 QUESTIONNAIRE 501

  • 20 RELATED REPORTS 506

USD 3,500 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.